BWX Technologies, Inc. $BWXT Shares Sold by Van ECK Associates Corp

Key Points

• Van ECK Associates reduced its BWX Technologies stake by 1.7%, selling 27,676 shares and retaining approximately 1.56 million shares valued at $303 million. Institutional investors collectively own 94.39% of the company.
• BWXT reported quarterly EPS of $1.07, beating estimates of $1.04, while revenue rose 18% year over year to $901.6 million. The company maintained fiscal 2026 EPS guidance of $4.70–$4.80.
• The stock traded at $153.12, near its 52-week low, amid mixed analyst sentiment; BWXT carries a consensus “Moderate Buy” rating and a $224.20 average price target. The company also declared a $0.27 quarterly dividend, yielding about 0.7%.

Van ECK Associates Corp cut its stake in BWX Technologies, Inc. (NYSE:BWXT - Free Report) by 1.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,556,784 shares of the technology company's stock after selling 27,676 shares during the period. Van ECK Associates Corp owned approximately 1.70% of BWX Technologies worth $303,028,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. acquired a new position in BWX Technologies during the second quarter worth $2,359,895,000. Bank of New York Mellon Corp purchased a new position in shares of BWX Technologies during the 2nd quarter worth $222,587,000. Bank of America Corp DE purchased a new position in shares of BWX Technologies during the 2nd quarter worth $202,020,000. Invesco Ltd. boosted its position in shares of BWX Technologies by 60.1% during the 3rd quarter. Invesco Ltd. now owns 2,549,150 shares of the technology company's stock valued at $469,987,000 after acquiring an additional 956,770 shares during the last quarter. Finally, William Blair Investment Management LLC acquired a new position in shares of BWX Technologies during the 2nd quarter valued at about $183,211,000. Institutional investors and hedge funds own 94.39% of the company's stock.

BWX Technologies Stock Performance

NYSE:BWXT opened at $153.12 on Friday. BWX Technologies, Inc. has a fifty-two week low of $147.74 and a fifty-two week high of $241.82. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.33 and a current ratio of 2.40. The company has a 50 day moving average price of $175.83 and a 200 day moving average price of $195.80. The stock has a market capitalization of $14.03 billion, a P/E ratio of 39.67, a PEG ratio of 2.44 and a beta of 0.76.

BWX Technologies (NYSE:BWXT - Get Free Report) last announced its earnings results on Monday, August 3rd. The technology company reported $1.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.04 by $0.03. BWX Technologies had a return on equity of 30.83% and a net margin of 10.11%.The company had revenue of $901.62 million for the quarter, compared to analyst estimates of $902.41 million. During the same quarter in the previous year, the company earned $1.02 earnings per share. The firm's quarterly revenue was up 18.0% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. Equities research analysts forecast that BWX Technologies, Inc. will post 4.75 EPS for the current year.

BWX Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Tuesday, August 18th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, August 18th. BWX Technologies's dividend payout ratio (DPR) is 27.98%.

Analyst Ratings Changes

BWXT has been the subject of several recent analyst reports. Wall Street Zen cut shares of BWX Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. BTIG Research reissued a "buy" rating and issued a $235.00 price target on shares of BWX Technologies in a research note on Tuesday, August 4th. Weiss Ratings lowered shares of BWX Technologies from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Wednesday. Truist Financial decreased their price objective on BWX Technologies from $212.00 to $202.00 and set a "hold" rating on the stock in a report on Friday, August 14th. Finally, Zacks Research lowered BWX Technologies from a "strong-buy" rating to a "hold" rating in a research report on Monday, May 11th. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, BWX Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $224.20.

Insider Buying and Selling

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $172.50, for a total value of $1,725,000.00. Following the completion of the transaction, the chief executive officer directly owned 192,491 shares of the company's stock, valued at $33,204,697.50. The trade was a 4.94% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

About BWX Technologies

BWX Technologies, Inc NYSE: BWXT is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company's core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source